Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Hyperion Defi Inc's Business Segments
Hyperion Defi Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Digital Assets
Total Revenue
$ 0
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Digital Assets99.9%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Digital Assets | $ 0 | 99.9% |
Description of Hyperion Defi Inc
Hyperion DeFi, Inc., originally established as PGP Holdings V, Inc. in 2014 and subsequently renamed, is a digital ophthalmic technology company and the first U.S. publicly listed firm building a strategic treasury of Hyperliquid's native token, HYPE. The company aims to provide shareholders with exposure to the Hyperliquid ecosystem, a blockchain platform focused on high-frequency finance. Hyperliquid is a layer one blockchain supporting on-chain perpetual futures and spot order books with rapid transaction speeds and high throughput. It includes the HyperEVM smart contract platform, which enables decentralized financial applications and non-custodial trading of digital assets such as Bitcoin, Ether, Ripple, Solana, and Sui. The HYPE token functions for staking rewards, fee reduction, transaction payments, and collateral in decentralized finance applications. Hyperliquid employs a mechanism to buy back and burn HYPE tokens using trading fees to reduce supply and support token value. Hyperion DeFi has staked HYPE tokens to generate revenue and plans to expand this strategy. As of early 2026, Hyperliquid ranks eleventh by market capitalization, generates approximately $1 billion in annual fees, and maintains significant trading volume and user engagement. Simultaneously, Hyperion DeFi is progressing with the development and registration of its Optejet ophthalmic liquid delivery device.
